N. Lange

发表

Less bleeding associated with apixaban versus other direct acting oral anticoagulation in solid organ transplant recipients

D. Salerno, H. Robbins, D. Jennings, 2021, Clinical transplantation.

Managing the significant interaction between XR tacrolimus and fluconazole in kidney transplant recipients.

D. Salerno, D. Tsapepas, Jessica Hedvat, 2020, Clinical transplantation.

COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era

A. Anamisis, D. Salerno, Marcus R. Pereira, 2022, American Journal of Transplantation.

Mammalian Target of Rapamycin Inhibitors and Survival in Heart Transplant Recipients: Miracle or Mirage?

W. Baker, M. Shullo, D. Jennings, 2018, Journal of the American College of Cardiology.

Immunosuppression considerations in simultaneous organ transplant

A. Anamisis, D. Salerno, D. Jennings, 2020, Pharmacotherapy.

Deceased donor renal transplantation in patients on apixaban at time of transplant surgery: A case series

J. Weiner, S. Sultan, Jennifer H Lee, 2020, Clinical transplantation.

Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients

D. Salerno, D. Jennings, J. Choe, 2022, Transplantation.

Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: A meta-analysis.

S. Restaino, Y. Naka, H. Takayama, 2018, International journal of cardiology.

Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID‐19 in solid organ transplant recipients

D. Salerno, Marcus R. Pereira, D. Jennings, 2022, American Journal of Transplantation.

Nirmatrelvir/ritonavir use: Managing clinically significant drug‐drug interactions with transplant immunosuppressants

L. Ratner, D. Salerno, Marcus R. Pereira, 2022, American Journal of Transplantation.

Management of Hepatic Coagulopathy in Bleeding and Nonbleeding Patients: An Evidence-Based Review

K. Berger, D. Salerno, M. Cushing, 2020, Journal of intensive care medicine.

Delayed calcineurin inhibitor introduction and renal outcomes in liver transplant recipients receiving basiliximab induction

E. Verna, D. Salerno, Robert S. Brown, 2018, Clinical transplantation.

Using known drug interactions to manage supratherapeutic calcineurin inhibitor concentrations

K. Berger, D. Salerno, D. Tsapepas, 2017, Clinical transplantation.

Managing the significant drug‐drug interaction between tacrolimus and letermovir in solid organ transplant recipients

A. Anamisis, D. Salerno, J. Scheffert, 2021, Clinical transplantation.

Comparing weight‐based dosing of tacrolimus XR in obese and non‐obese renal transplant recipients

D. Salerno, Jessica Hedvat, N. Lange, 2021, Clinical transplantation.

Elevated posaconazole trough concentrations are not associated with increased risk for posaconazole toxicity in lung transplant recipients

D. Salerno, J. Scheffert, N. Lange, 2022, Clinical transplantation.

Nitazoxanide treatment for norovirus infection in solid organ transplant recipients

A. Anamisis, D. Salerno, D. Jennings, 2022, Clinical Transplantation.

An evaluation of PJP prophylaxis and anemia among renal transplant recipients

D. Salerno, G. Dube, Jessica Hedvat, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Obesity is associated with a higher incidence of rejection in patients on belatacept: a pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials.

S. Husain, S. Mohan, D. Tsapepas, 2024, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.